Compugen Ltd.
ANTI-VSIG10 ANTIBODIES AND METHODS OF USE
Last updated:
Abstract:
A monoclonal or polyclonal antibody or an antigen binding fragment thereof comprising an antigen binding site that binds specifically to an isolated polypeptide comprising amino acids of the soluble ectodomain of a sequence selected from the group consisting of SEQ ID NOs:3 and 5, or a fragment, thereof, or an epitope thereof; for use in treatment of cancer, wherein immune cells in the microenvironment of said cancer express said isolated polypeptide.
Status:
Application
Type:
Utility
Filling date:
8 Jun 2018
Issue date:
27 Aug 2020